What is the “Developing research on nocturnal oxygen therapy in pulmonary fibrosis” survey?

This survey has been developed by Monash University. The aim of the survey is to gather information about the effects of nocturnal oxygen therapy and improve its use in people living with pulmonary fibrosis.

Who can take the “Developing research on nocturnal oxygen therapy in pulmonary fibrosis” survey?

Any person living with pulmonary fibrosis can participate in the survey.

What is the purpose of the “Developing research on nocturnal oxygen therapy in pulmonary fibrosis” survey?

Approximately 1 in 3 people living with pulmonary fibrosis have a low oxygen level in their sleep, and this is associated with a reduced quality of life. However, little is known about assessing low oxygen levels during sleep, or the effects of using nocturnal oxygen therapy. The aim of the survey is to establish a global perspective of patients and caregivers on issues relating to the use of nocturnal oxygen therapy in pulmonary fibrosis.

If you want to learn more about the survey, please click on the links to be taken to the survey. If you choose to take part, you will complete a short questionnaire asking your views on the use and research about nocturnal oxygen therapy in pulmonary fibrosis.

This survey is anonymous and you can leave the survey at any time.

Please note the deadline for responses is the 13 October 2024.